WEBULL
News
CELUW
0.0214
0.00%
0.00
Weekly Report: what happened at CELUW last week (1201-1205)?
Weekly Report · 4d ago
CELULARITY INC - FDA LETTER DOES NOT RESTRICT MANUFACTURING OR SHIPPING - SEC FILING
Reuters · 6d ago
FDA Warns Celularity Over Marketing Claims for Interfyl
Reuters · 6d ago
Weekly Report: what happened at CELUW last week (1124-1128)?
Weekly Report · 12/01 09:55
Weekly Report: what happened at CELUW last week (1117-1121)?
Weekly Report · 11/24 09:59
Weekly Report: what happened at CELUW last week (1110-1114)?
Weekly Report · 11/17 09:59
Weekly Report: what happened at CELUW last week (1103-1107)?
Weekly Report · 11/10 09:57
Weekly Report: what happened at CELUW last week (1027-1031)?
Weekly Report · 11/03 09:56
CELULARITY INC - ENTERS SECURITIES PURCHASE AGREEMENT FOR PRIVATE PLACEMENT - SEC FILING
Reuters · 10/28 13:31
Celularity Inc. Sells Series A Preferred Stock and Warrants in $2 Million Private Placement
Reuters · 10/28 13:30
Weekly Report: what happened at CELUW last week (1020-1024)?
Weekly Report · 10/27 09:59
Weekly Report: what happened at CELUW last week (1013-1017)?
Weekly Report · 10/20 09:57
CELULARITY ANNOUNCES PEER-REVIEWED PUBLICATION OF PHASE 2 CLINICAL TRIAL RESULTS DEMONSTRATING THE SAFETY AND EFFICACY OF HUMAN PLACENTA-DERIVED CELLS (PDA-002) FOR DIABETIC FOOT ULCERS COMPLICATED BY PERIPHERAL ARTERY DISEASE
Reuters · 10/14 12:45
Weekly Report: what happened at CELUW last week (1006-1010)?
Weekly Report · 10/13 09:59
Weekly Report: what happened at CELUW last week (0929-1003)?
Weekly Report · 10/06 09:56
Weekly Report: what happened at CELUW last week (0922-0926)?
Weekly Report · 09/29 09:57
Weekly Report: what happened at CELUW last week (0915-0919)?
Weekly Report · 09/22 09:57
Weekly Report: what happened at CELUW last week (0908-0912)?
Weekly Report · 09/15 10:40
Weekly Report: what happened at CELUW last week (0901-0905)?
Weekly Report · 09/08 10:43
Weekly Report: what happened at CELUW last week (0825-0829)?
Weekly Report · 09/01 10:39
More
Webull provides a variety of real-time CELUW stock news. You can receive the latest news about Celularity Inc through multiple platforms. This information may help you make smarter investment decisions.
About CELUW
Celularity Inc. is a regenerative and cellular medicine company. It is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells (MLASCs), T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. It also develops, manufactures and commercializes advanced biomaterial products derived from structural tissue components of the postpartum placental tissues, including the umbilical cord. Its advanced biomaterials include Celularity Tendon Wrap, FUSE Bone Void Filler and Celularity Placental Matrix. Its advanced biomaterial products include Biovance and Interfyl products. Its platform is Celularity IMPACT (Immuno-Modulatory Placental-derived Allogeneic Cell Therapy).